NYSE:CTRA - US1270971039 - Common Stock
TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 6.62B | 5.46B | 5.91B | 9.05B | 3.45B | |||
Cost Of Goods | 1.16B | 1.08B | 1.06B | 1.04B | 819.00M | |||
Gross Profit | 5.46B | 4.38B | 4.85B | 8.01B | 2.63B | |||
Operating Expenses | 3.40B | 2.99B | 2.69B | 2.73B | 958.00M | |||
Research and Development | 29.00M | 25.00M | 20.00M | 29.00M | 18.00M | |||
Selling, General, and Administrative Expenses | 1.32B | 1.13B | 1.03B | 1.06B | 247.00M | |||
Operating Income | 2.07B | 1.39B | 2.15B | 5.28B | 1.67B | |||
Interest Income/Expense | -103.00M | -18.00M | -14.00M | -63.00M | -62.00M | |||
Other Income/Expense | -18.00M | -26.00M | -12.00M | -5.00M | 0.00 | |||
Non Recurring Items | -7.00M | 3.00M | 0.00 | -42.00M | -108.00M | |||
Income Before Taxes | 1.94B | 1.34B | 2.13B | 5.17B | 1.50B | |||
Income Tax | 366.00M | 224.00M | 503.00M | 1.10B | 344.00M | |||
Net Income | 1.58B | 1.12B | 1.62B | 4.06B | 1.16B | |||
EBITDA | 4.10B | 3.21B | 3.79B | 6.91B | 2.37B | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | 2.08 | 1.50 | 2.13 | 5.08 | 2.30 | |||
Non GAAP EPS | 2.09 | 1.69 | 2.28 | 4.94 | 1.99 | |||
Statistics | ||||||||
Gross Profit Margin | 82.52% | 80.21% | 81.99% | 88.45% | 76.25% | |||
Profit Margin | 23.80% | 20.52% | 27.39% | 44.82% | 33.57% | |||
Operating Profit Margin | 31.25% | 25.39% | 36.42% | 58.33% | 48.48% |
All data in USD